Skip to main content

Animations

MJFF Publications

6771 - 6780 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2023
  • 2017
  • 2016
  • 2020
  • 2020
  • 2015
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.04.007
    Citation Count: 39
  • Summary Details
    OPEN
    Title: A novel approach to study markers of dopamine signaling in peripheral immune cells
    Journal Name: Journal of Immunological Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jim.2019.112686
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Anxiety Change After Dopamine Therapy in Parkinson Disease is Independent of Motor Improvement
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2023.09.001
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Beyond L-DOPA: hope for Parkinson’s treatment and diagnosis
    Journal Name: EBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2017.09.009
    Citation Count: 0
  • Summary Details
    OPEN
    Title: White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.001
    Citation Count: 88
  • Summary Details
    RESTRICTED
    Title: Decision Support for Medication Change of Parkinson's Disease Patients
    Journal Name: Computer Methods and Programs in Biomedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105552
    Citation Count: 25
  • Summary Details
    OPEN
    Title: An Explainable Machine Learning Model for Early Detection of Parkinson's Disease using LIME on DaTSCAN Imagery
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2020.104041
    Citation Count: 193
  • Summary Details
    OPEN
    Title: tranSMART Foundation Datathon 1.0: The cross neurodegenerative diseases challenge
    Journal Name: Applied & Translational Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.atg.2015.08.004
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Pervasive cis effects of variation in copy number of large tandem repeats on local DNA methylation and gene expression
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.03.016
    Citation Count: 33
  • Summary Details
    RESTRICTED
    Title: Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease
    Journal Name: Artificial Intelligence in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.artmed.2020.101807
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.